Cargando…

Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study

BACKGROUND: In this study, to clarify the evolving background of people with non-alcoholic fatty liver disease (NAFLD), we compared the current prevalence of NAFLD with that of 2 decades ago. METHODS: We included two cohorts. The past cohort was from 1994 to 1997 and included 4279 men and 2502 women...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamura, Takuro, Hashimoto, Yoshitaka, Hamaguchi, Masahide, Obora, Akihiro, Kojima, Takao, Fukui, Michiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130346/
https://www.ncbi.nlm.nih.gov/pubmed/34001028
http://dx.doi.org/10.1186/s12876-021-01809-2
_version_ 1783694503439237120
author Okamura, Takuro
Hashimoto, Yoshitaka
Hamaguchi, Masahide
Obora, Akihiro
Kojima, Takao
Fukui, Michiaki
author_facet Okamura, Takuro
Hashimoto, Yoshitaka
Hamaguchi, Masahide
Obora, Akihiro
Kojima, Takao
Fukui, Michiaki
author_sort Okamura, Takuro
collection PubMed
description BACKGROUND: In this study, to clarify the evolving background of people with non-alcoholic fatty liver disease (NAFLD), we compared the current prevalence of NAFLD with that of 2 decades ago. METHODS: We included two cohorts. The past cohort was from 1994 to 1997 and included 4279 men and 2502 women. The current cohort was from 2014 to 2017 and included 8918 men and 7361 women. NAFLD was diagnosed by abdominal ultrasonography. RESULTS: The prevalence of NAFLD increased in both genders throughout these 2 decades (18.5% in the past cohort and 27.1% in the current cohort for men; and 8.0% in the past cohort and 9.4% in the current cohort for women). The prevalence of hyperglycemia increased, whereas the prevalence of low high-density lipoprotein cholesterol levels and hypertriglyceridemia significantly decreased. There was no significant difference in the mean body mass index. Multivariate analysis revealed that the prevalence of obesity and body mass index were significantly associated with the prevalence of NAFLD in both the past and current cohorts. CONCLUSIONS: The incidence of NAFLD significantly increased throughout these 2 decades, and obesity is the most prevalent factor. Thus, body weight management is an essential treatment option for NAFLD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-021-01809-2.
format Online
Article
Text
id pubmed-8130346
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81303462021-05-18 Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study Okamura, Takuro Hashimoto, Yoshitaka Hamaguchi, Masahide Obora, Akihiro Kojima, Takao Fukui, Michiaki BMC Gastroenterol Research BACKGROUND: In this study, to clarify the evolving background of people with non-alcoholic fatty liver disease (NAFLD), we compared the current prevalence of NAFLD with that of 2 decades ago. METHODS: We included two cohorts. The past cohort was from 1994 to 1997 and included 4279 men and 2502 women. The current cohort was from 2014 to 2017 and included 8918 men and 7361 women. NAFLD was diagnosed by abdominal ultrasonography. RESULTS: The prevalence of NAFLD increased in both genders throughout these 2 decades (18.5% in the past cohort and 27.1% in the current cohort for men; and 8.0% in the past cohort and 9.4% in the current cohort for women). The prevalence of hyperglycemia increased, whereas the prevalence of low high-density lipoprotein cholesterol levels and hypertriglyceridemia significantly decreased. There was no significant difference in the mean body mass index. Multivariate analysis revealed that the prevalence of obesity and body mass index were significantly associated with the prevalence of NAFLD in both the past and current cohorts. CONCLUSIONS: The incidence of NAFLD significantly increased throughout these 2 decades, and obesity is the most prevalent factor. Thus, body weight management is an essential treatment option for NAFLD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-021-01809-2. BioMed Central 2021-05-17 /pmc/articles/PMC8130346/ /pubmed/34001028 http://dx.doi.org/10.1186/s12876-021-01809-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Okamura, Takuro
Hashimoto, Yoshitaka
Hamaguchi, Masahide
Obora, Akihiro
Kojima, Takao
Fukui, Michiaki
Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study
title Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study
title_full Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study
title_fullStr Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study
title_full_unstemmed Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study
title_short Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study
title_sort clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the nagala study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130346/
https://www.ncbi.nlm.nih.gov/pubmed/34001028
http://dx.doi.org/10.1186/s12876-021-01809-2
work_keys_str_mv AT okamuratakuro clinicalcharacteristicsandlongitudinalchangesofpatientswithnonalcoholicfattyliverdiseasein2decadesthenagalastudy
AT hashimotoyoshitaka clinicalcharacteristicsandlongitudinalchangesofpatientswithnonalcoholicfattyliverdiseasein2decadesthenagalastudy
AT hamaguchimasahide clinicalcharacteristicsandlongitudinalchangesofpatientswithnonalcoholicfattyliverdiseasein2decadesthenagalastudy
AT oboraakihiro clinicalcharacteristicsandlongitudinalchangesofpatientswithnonalcoholicfattyliverdiseasein2decadesthenagalastudy
AT kojimatakao clinicalcharacteristicsandlongitudinalchangesofpatientswithnonalcoholicfattyliverdiseasein2decadesthenagalastudy
AT fukuimichiaki clinicalcharacteristicsandlongitudinalchangesofpatientswithnonalcoholicfattyliverdiseasein2decadesthenagalastudy